Publications

Everolimus Plus Endocrine Therapy for Postmenopausal Women With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer A Clinical Trial

AuthID
P-00P-2MB

Author(s)

Royce, M

Bachelot, T

Villanueva, C

Ozguroglu, M

Azevedo, SJ

Cruz, FM

Debled, M

Hegg, R

Toyama, T

Falkson, C

Jeong, J

Srimuninnimit, V

Gradishar, WJ

Arce, C

Ridolfi, A

Lin, CJ

Cardoso, F

Document Type

Article

Year published

2018

Published

in JAMA ONCOLOGY, ISSN: 2374-2437

Volume: 4, Issue: 7, Pages: 977-984 (8)

Indexing

Wos^®

Scopus^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1001/jamaoncol.2018.0060

SCOPUS: 2-s2.0-85050538909

Wos: WOS:000438486000017

Source Identifiers

ISSN: 2374-2437

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Everolimus Plus Endocrine Therapy for Postmenopausal Women With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer A Clinical Trial

Useful Links

Get Help

Federated Authentication (Click on the image)

Everolimus Plus Endocrine Therapy for Postmenopausal Women With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer A Clinical Trial

Useful Links

Get Help